Bayer AG, Johnson & Johnson’s Xarelto Gets FDA Priority Review

RARITAN, N.J., July 9, 2012 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen R&D) announced today the U.S. Food and Drug Administration (FDA) has assigned a priority review designa…
Read the full story: BioSpace.com Featured News